The agenda is: Preparation of positions on drug evaluation: Inrebic (fedratinibum) under the drug program: "Treatment of primary myelofibrosis and secondary myelofibrosis in the course of polycythemia vera and essential thrombocythemia (ICD-10 D47.1)", Kesimpta (ofatumumabum) under the drug...
The European Commission (EC) has granted conditional marketing authorisation for sotorasib, a first-in-class KRASG12C inhibitor, for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior line of systemic...
The draft ordinance of the Minister of Health amending the ordinance on enriching substances added to food was submitted for consultation.
The Council will meet on January 10 (Monday). The agenda is: Preparation of a position on the evaluation of the drug Jardiance (empagliflozinum) in the indication: chronic heart failure in adult patients with reduced left ventricular ejection fraction (LVEF ≤ 40%) and persistent disease symptoms...
The decision is related to the finding of a quality defect.
© 2023 Medexpress. All Rights Reserved
